Background -The purpose of this study
Background -The purpose of this study was to identify factors on which European general practitioners (GPs) base their decisions to admit to hospital patients with lower respiratory tract infections (LRTI). Methods -A survey was carried out from December 1993 to January 1994 to identify factors that affect GPs' decisions to admit to hospital patients with LRTI by collecting data on 2056 patients from 605 GPs in France, Germany, Italy, Spain, and the UK.
Results -Only 93 (4.5%) of the patients included in the study were admitted to hospital. Univariate analysis showed that age > 60 years, institutionalisation of the patient, concomitant diseases, cardiac insufficiency, asthma, a diagnosis ofpneumonia, and clinical signs such as chest pain, cyanosis, tachypnoea and hypotension significantly (odds ratio (OR) > 2.0, p < 0.002) influenced the decision to admit to hospital. No influence could be shown for sex, smoking habits, history of bronchiectasis or chronic bronchitis, the presence of fever, chills, myalgia, cough or purulent sputum, and the diagnoses of acute bronchitis, influenza or exacerbation of chronic bronchitis. In the multivariate analysis only the presence of chest pain (OR 2.3,95% confidence interval (CI) 1.5 to 3.5), cyanosis (OR 4.1, 95% CI 2.4 to 7.1), dyspnoea (OR 4.9, 95% CI 3.1 to 7.9), and hypotension (OR 2.9, 95% CI 1.6 to 5.2), as well as a diagnosis of pneumonia (OR 6.6, 95% CI 4.3 to 10) (all p < 0.00001) remained as factors that significantly affected the decision to admit to hospital. Conclusions -Clinical signs of severe infection and a diagnosis of pneumonia are the main factors that induce GPs to admit patients with LRTI to hospital in Europe. (Thorax 1996; 51:1017 -1022 Keywords: hospitalisation, community acquired pneumonia, chronic bronchitis, lower respiratory tract infection.
Infections of the respiratory tract are the most common types of infectious diseases in developed countries. In the USA it has been estimated that over 200 million episodes of respiratory tract infections occur each year, corresponding to an incidence of nearly one infection per inhabitant per year.' In this study the morbidity of these infections was found to account for an estimated 75 million physician visits and almost 150 million days lost from work per year. calculated using a computed statistical analysis system (GraphPad, San Diego, USA).
All factors which showed a significant association with the decision to admit to hospital by univariate analysis (p < 0.01) were entered into a multivariate analysis performed by multiway frequency tables, measures of association, and the log-linear model using the P4F routines of the BMDP software package (University of California, Berkeley, USA). The log-linear model was used because the response variable was a binomial random variable (admission or no admission to hospital). Partial association tests were used to analyse the significance of deleting a particular effect from the model by calculation of the likelihood ratio. X2 and marginal association tests were used to test the significance of deleting an effect from the model which contains all effects after summing over levels of categorical variables not included in the effect by calculation of the Pearson X2. Because of the multiple tests and the relatively small number of patients admitted to hospital, only p values of < 0.00001 were considered significant in the multivariate analysis.
Results

HOSPITAL ADMISSIONS
Only 93 patients (4.5%) of the 2056 patients with LRTI included in this study were admitted to hospital. Important sociodemographic data of the patients who were and were not admitted to hospital are shown in table 1. In comparison with the whole study population, patients admitted to hospital were older (fig 1) , were institutionalised more frequently, smoked less (table 1) , and more often had concomitant diseases, especially chronic bronchitis, asthma and cardiac failure (table 2), than those treated at home. Analysis of hospital admissions in the five countries showed a higher than average rate of hospital admissions in the UK (9.0%) and France (5.1 %), and a lower than average rate in Spain, Germany, and Italy (fig 2) , although there were no significant differences in the frequency of each diagnosis and the patient population between the five countries. Age groups (years) Figure 1 Age distribution of the study cohort; solid, percentage ofpatients admitted to hospital; shaded, percentage ofpatients not admitted to hospital. The most frequent symptoms were cough, fever, and expectoration of purulent sputum. Signs of more severe infection were only seen in a few patients (cyanosis 6.5%, hypotension 6.6%). With the exception of cough (17.9%) and dyspnoea (12.3%), only a small proportion of all symptoms had been present before the onset of the current LRTI ( < 5%), but no differences could be observed between patients admitted and not admitted to hospital. In contrast, patients admitted to hospital more often showed signs of more severe types of infections such as chest pain, cyanosis, dyspnoea or hypotension, whereas no differences were seen in the incidence of fever, chills, myalgia, cough, purulent sputum, and focal signs during auscultation at the time of first presentation ( fig 3) . is a strong and useful instrument for making this decision. It is surprising to see how closely the practice of GPs in Europe agrees with the guidelines for the management of community acquired pneumonia recently published by the American Thoracic Society (ATS). Specific risk factors identified by the ATS to increase the risk of death or the risk of a complicated course in patients with community acquired pneumonia are age over 65 years, severe concomitant diseases such as chronic obstructive airway disease or cardiac failure, and physical findings of severe infection such as dyspnoea, hypotension, or hypoxaemia. Admission to hospital of patients with community acquired pneumonia is strongly recommended when these risk factors are present, especially if they occur in combination. In our study most of these factors showed a significant association with the GPs' decision to admit to hospital patients with LRTI, reflecting a wide agreement between such recommendations and current clinical practice.
The decision to admit patients with LRTI to hospital is important, both from a clinical point Our study does have some shortcomings. Firstly, due to the design of the study it was not possible to verify the diagnosis given by the GPs to an individual patient. However, we feel that this is unimportant as it does not matter how the GP makes the diagnosis, but it is what he or she thinks with regard to the management of the patient with LRTI that is important. Secondly, since the patients were not followed up we cannot draw any conclusions with regard to the actual necessity of hospital admission in individual cases. Nevertheless, since the primary aim of our study was to identify the criteria currently used by European GPs in their decision to admit to hospital patients with LRTI, this does not influence our conclusions. However, the crite- With regard to the currently used decision criteria of GPs identified in our study, we feel that future recommendations should lay emphasis on the careful assessment of patientrelated risk factors and on the physical examination instead of using scoring systems. Our finding that the criteria on which European GPs currently base their decision to admit to hospital a patient with LRTI agree with both recent international recommendations and significant risk factors for mortality or a complicated course of LRTI is encouraging and reflects good clinical practice.
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